ct-996
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 9, 2023 (NCT05814107)
Timeline
Indications
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07112872 | Phase 2 | Aug 19, 2025 | Roche |
| NCT07081958 | Phase 2 | Jul 29, 2025 | Roche |
| NCT06982131 | Phase 1 | Jun 4, 2025 | Roche |
| NCT06809608 | Phase 1 | Feb 13, 2025 | Roche |
| NCT05814107 | Phase 1 | May 9, 2023 | Carmot Therapeutics, Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 4 | 4 | 2 | 2025 |
| Carmot Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1